RXO jumps after C.H. Robinson agrees to acquire the company

RXO Inc. (RXO) is up 21.0% today. Here is some analysis on what might have caused this price movement.

Analysis: The sharp move appears tied to C.H. Robinson’s agreement to acquire RXO in a cash-and-stock transaction, which immediately reset RXO’s valuation closer to the deal price. Investors also seem to be reacting to the takeover premium and the expectation that RXO shareholders will participate in part of the combined company’s upside.

Details:

C.H. Robinson announced a deal to buy RXO in a transaction valued at about $5.8 billion, making M&A the clearest catalyst for the stock’s jump.

Under the merger terms, RXO shareholders would receive $17.25 in cash plus 0.0856 shares of C.H. Robinson for each RXO share, implying a value around $30.25 based on C.H. Robinson’s prior closing price.

The implied consideration represented a sizable premium to RXO’s recent trading levels, which often leads target-company shares to surge toward the offered value once a deal is announced.

SEC merger materials also show support arrangements with a significant RXO shareholder and financing commitments for the cash portion, which may have strengthened confidence that the transaction can move forward, subject to approvals.

Sources:

SEC, FreightWaves, AP News

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

EARLY ACCESS

Receive RXO Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$RXO Hedge Fund Activity

We have seen 149 institutional investors add shares of $RXO stock to their portfolio, and 107 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

FINEPOINT CAPITAL LP removed 4,718,173 shares (-46.8%) from their portfolio in Q2 2026, for an estimated $130,174,393
FIL LTD removed 3,925,000 shares (-59.9%) from their portfolio in Q2 2026, for an estimated $108,290,750
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 2,613,414 shares (+inf%) to their portfolio in Q2 2026, for an estimated $72,104,092
MAPLE ROCK CAPITAL PARTNERS INC. added 2,583,655 shares (+inf%) to their portfolio in Q2 2026, for an estimated $71,283,041
HOOD RIVER CAPITAL MANAGEMENT LLC added 2,026,330 shares (+45.5%) to their portfolio in Q2 2026, for an estimated $55,906,444
FRONTIER CAPITAL MANAGEMENT CO LLC removed 1,625,314 shares (-61.3%) from their portfolio in Q2 2026, for an estimated $44,842,413
UBS GROUP AG removed 1,208,185 shares (-57.1%) from their portfolio in Q2 2026, for an estimated $33,333,824

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$RXO Analyst Ratings

Wall Street analysts have issued reports on $RXO in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Stifel issued a "Buy" rating on 05/15/2026

To track analyst ratings and price targets for $RXO, check out Quiver Quantitative's $RXO forecast page.

$RXO Price Targets

Multiple analysts have issued price targets for $RXO recently. We have seen 8 analysts offer price targets for $RXO in the last 6 months, with a median target of $24.0.

Here are some recent targets:

Ariel Rosa from Citigroup set a target price of $30.0 on 07/09/2026
Thomas Wadewitz from UBS set a target price of $26.0 on 06/30/2026
Brandon Oglenski from Barclays set a target price of $28.0 on 06/26/2026
J. Bruce Chan from Stifel set a target price of $22.0 on 05/15/2026
Ravi Shanker from Morgan Stanley set a target price of $22.0 on 05/08/2026
Christian Wetherbee from Wells Fargo set a target price of $22.0 on 05/08/2026
Bascome Majors from Susquehanna set a target price of $18.0 on 05/08/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.